We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BWXT icon
176
BWX Technologies
BWXT
$15.6B
$3.17M 0.02%
56,046
-1,126
-2% -$62.9K
KMB icon
177
Kimberly-Clark
KMB
$36.5B
$3.09M 0.02%
21,875
-354
-2% -$48.9K
NI icon
178
NiSource
NI
$20.4B
$3.09M 0.02%
135,887
+293
+0.2% +$7.07K
MSM icon
179
MSC Industrial Direct
MSM
$6.86B
$3.01M 0.02%
41,350
+148
+0.4% +$9.54K
MANT
180
DELISTED
Mantech International Corp
MANT
$3M 0.02%
43,853
-648
-1% -$47.7K
WPC icon
181
W.P. Carey
WPC
$16.4B
$2.98M 0.02%
44,904
-368
-0.8% -$22.9K
KR icon
182
Kroger
KR
$34.8B
$2.95M 0.02%
87,260
-56
-0.1% -$1.82K
MLAB icon
183
Mesa Laboratories
MLAB
$574M
$2.91M 0.02%
13,414
-328
-2% -$75.6K
FITB
184
Fifth Third Bancorp
FITB
$51.8B
$2.9M 0.02%
150,437
– –
VVV icon
185
Valvoline
VVV
$4.51B
$2.81M 0.02%
+145,112
New +$2.46M
DCI icon
186
Donaldson
DCI
$11.4B
$2.78M 0.02%
59,730
-12,545
-17% -$555K
IEFA icon
187
iShares Core MSCI EAFE ETF
IEFA
$196B
$2.78M 0.02%
48,599
-2,556
-5% -$139K
EGOV
188
DELISTED
NIC Inc
EGOV
$2.77M 0.02%
120,500
-450
-0.4% -$10.6K
STE icon
189
Steris
STE
$23.1B
$2.75M 0.02%
17,887
+401
+2% +$61.1K
COHR icon
190
Coherent
COHR
$74.2B
$2.69M 0.02%
57,015
-214
-0.4% -$8.48K
ATR icon
191
AptarGroup
ATR
$8.61B
$2.65M 0.02%
23,667
-1,000
-4% -$106K
HOMB icon
192
Home BancShares
HOMB
$6.18B
$2.63M 0.02%
171,205
+2,278
+1% +$32K
SCL icon
193
Stepan Co
SCL
$1.48B
$2.63M 0.02%
27,083
+4,527
+20% +$426K
RBA icon
194
RB Global
RBA
$17.5B
$2.61M 0.02%
63,818
-1,442
-2% -$59K
UFPI icon
195
UFP Industries
UFPI
$5.19B
$2.59M 0.02%
52,334
-910
-2% -$38.7K
NRC icon
196
NRC Health Common Stock
NRC
$450M
$2.52M 0.02%
+43,273
New +$2.29M
PETS icon
197
PetMed Express
PETS
$42.3M
$2.43M 0.02%
+68,074
New +$2.36M
DUK icon
198
Duke Energy
DUK
$97.3B
$2.41M 0.02%
30,185
-56
-0.2% -$4.73K
GWW icon
199
W.W. Grainger
GWW
$60.2B
$2.4M 0.02%
7,625
+700
+10% +$202K
EFA icon
200
iShares MSCI EAFE ETF
EFA
$80.2B
$2.35M 0.02%
38,597
-100
-0.3% -$5.78K
6 7
8
9 10

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.